161 related articles for article (PubMed ID: 11526472)
1. Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder.
Lerer B; Macciardi F; Segman RH; Adolfsson R; Blackwood D; Blairy S; Del Favero J; Dikeos DG; Kaneva R; Lilli R; Massat I; Milanova V; Muir W; Noethen M; Oruc L; Petrova T; Papadimitriou GN; Rietschel M; Serretti A; Souery D; Van Gestel S; Van Broeckhoven C; Mendlewicz J
Mol Psychiatry; 2001 Sep; 6(5):579-85. PubMed ID: 11526472
[TBL] [Abstract][Full Text] [Related]
2. Allelic association analysis of the 5-HT2C receptor gene in bipolar affective disorder.
Gutiérrez B; Fañanás L; Arranz MJ; Vallès V; Guillamat R; van Os J; Collier D
Neurosci Lett; 1996 Jul; 212(1):65-7. PubMed ID: 8823764
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in allelic frequencies of the 5-HT2C Cys23Ser polymorphism in psychiatric patients and healthy volunteers: findings from an association study.
Fehr C; Szegedi A; Anghelescu I; Klawe C; Hiemke C; Dahmen N
Psychiatr Genet; 2000 Jun; 10(2):59-65. PubMed ID: 10994642
[TBL] [Abstract][Full Text] [Related]
4. Association study between novel promoter variants at the 5-HT2C receptor gene and human patients with bipolar affective disorder.
Gutiérrez B; Arias B; Papiol S; Rosa A; Fañanás L
Neurosci Lett; 2001 Aug; 309(2):135-7. PubMed ID: 11502363
[TBL] [Abstract][Full Text] [Related]
5. HTR2C (cys23ser) polymorphism influences early onset in bipolar patients in a large European multicenter association study.
Massat I; Lerer B; Souery D; Blackwood D; Muir W; Kaneva R; Nöthen MM; Oruc L; Papadimitriou GN; Dikeos D; Serretti A; Bellivier F; Golmard JL; Milanova V; Del-Favero J; Van Broeckhoven C; Mendlewicz J
Mol Psychiatry; 2007 Sep; 12(9):797-8. PubMed ID: 17767148
[No Abstract] [Full Text] [Related]
6. Serotonin 5-HT
Land MA; Chapman HL; Davis-Reyes BD; Felsing DE; Allen JA; Moeller FG; Elferink LA; Cunningham KA; Anastasio NC
Sci Rep; 2019 Nov; 9(1):16737. PubMed ID: 31723224
[TBL] [Abstract][Full Text] [Related]
7. Serotonergic candidate genes and puerperal psychosis: an association study.
Kumar HB; Purushottam M; Kubendran S; Gayathri P; Mukherjee O; Murthy AR; Ghosh S; Chandra P; Reddy YC; Benegal V; Brahmachari SK; Jain S
Psychiatr Genet; 2007 Oct; 17(5):253-60. PubMed ID: 17728663
[TBL] [Abstract][Full Text] [Related]
8. Modification of human 5-HT(2C) receptor function by Cys23Ser, an abundant, naturally occurring amino-acid substitution.
Okada M; Northup JK; Ozaki N; Russell JT; Linnoila M; Goldman D
Mol Psychiatry; 2004 Jan; 9(1):55-64. PubMed ID: 14699441
[TBL] [Abstract][Full Text] [Related]
9. Allelic variation of the 5-HT2C receptor (HTR2C) in bulimia nervosa and binge eating disorder.
Burnet PW; Smith KA; Cowen PJ; Fairburn CG; Harrison PJ
Psychiatr Genet; 1999 Jun; 9(2):101-4. PubMed ID: 10412190
[TBL] [Abstract][Full Text] [Related]
10. Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways.
Frisch A; Postilnick D; Rockah R; Michaelovsky E; Postilnick S; Birman E; Laor N; Rauchverger B; Kreinin A; Poyurovsky M; Schneidman M; Modai I; Weizman R
Mol Psychiatry; 1999 Jul; 4(4):389-92. PubMed ID: 10483058
[TBL] [Abstract][Full Text] [Related]
11. Association analysis of the 5-HT(6) receptor polymorphism (C267T) in mood disorders.
Hong CJ; Tsai SJ; Cheng CY; Liao WY; Song HL; Lai HC
Am J Med Genet; 1999 Dec; 88(6):601-2. PubMed ID: 10581475
[TBL] [Abstract][Full Text] [Related]
12. Identification, expression, and pharmacology of a Cys23-Ser23 substitution in the human 5-HT2c receptor gene (HTR2C).
Lappalainen J; Zhang L; Dean M; Oz M; Ozaki N; Yu DH; Virkkunen M; Weight F; Linnoila M; Goldman D
Genomics; 1995 May; 27(2):274-9. PubMed ID: 7557992
[TBL] [Abstract][Full Text] [Related]
13. No association of a functional polymorphism in the dopamine D2 receptor promoter region with bipolar or unipolar affective disorders.
Furlong RA; Coleman TA; Ho L; Rubinsztein JS; Walsh C; Paykel ES; Rubinsztein DC
Am J Med Genet; 1998 Sep; 81(5):385-7. PubMed ID: 9754623
[TBL] [Abstract][Full Text] [Related]
14. The serotonin transporter (5-HTTLPR) but not serotonin receptor (5-HT2C Cys23Ser) variant is associated with bipolar I disorder in Kurdish population from Western Iran.
Mohammadi S; Khazaie H; Rahimi Z; Vaisi-Raygani A; Zargooshi N; Rahimi Z
Neurosci Lett; 2015 Mar; 590():91-5. PubMed ID: 25596490
[TBL] [Abstract][Full Text] [Related]
15. Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders.
Furlong RA; Ho L; Walsh C; Rubinsztein JS; Jain S; Paykel ES; Easton DF; Rubinsztein DC
Am J Med Genet; 1998 Feb; 81(1):58-63. PubMed ID: 9514589
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation of the 5-HT2A receptor gene and bipolar affective disorder.
Gutiérrez B; Bertranpetit J; Collier D; Arranz MJ; Vallès V; Guillamat R; Van Os J; Fañanás L
Hum Genet; 1997 Oct; 100(5-6):582-4. PubMed ID: 9341875
[TBL] [Abstract][Full Text] [Related]
17. HTR2C Cys23Ser polymorphism in relation to CSF monoamine metabolite concentrations and DSM-III-R psychiatric diagnoses.
Lappalainen J; Long JC; Virkkunen M; Ozaki N; Goldman D; Linnoila M
Biol Psychiatry; 1999 Sep; 46(6):821-6. PubMed ID: 10494451
[TBL] [Abstract][Full Text] [Related]
18. 5-HT2C (HTR2C) serotonin receptor gene polymorphism associated with the human personality trait of reward dependence: interaction with dopamine D4 receptor (D4DR) and dopamine D3 receptor (D3DR) polymorphisms.
Ebstein RP; Segman R; Benjamin J; Osher Y; Nemanov L; Belmaker RH
Am J Med Genet; 1997 Feb; 74(1):65-72. PubMed ID: 9034010
[TBL] [Abstract][Full Text] [Related]
19. Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients.
Masellis M; Basile V; Meltzer HY; Lieberman JA; Sevy S; Macciardi FM; Cola P; Howard A; Badri F; Nöthen MM; Kalow W; Kennedy JL
Neuropsychopharmacology; 1998 Aug; 19(2):123-32. PubMed ID: 9629566
[TBL] [Abstract][Full Text] [Related]
20. Association studies of 5-HT2A and 5-HT2C serotonin receptor gene polymorphisms with prophylactic lithium response in bipolar patients.
Dmitrzak-Weglarz M; Rybakowski JK; Suwalska A; Słopień A; Czerski PM; Leszczyńska-Rodziewicz A; Hauser J
Pharmacol Rep; 2005; 57(6):761-5. PubMed ID: 16382194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
